易瑞生物: 关于“易瑞转债”预计触发赎回条件的提示性公告

Core Viewpoint - Shenzhen Yirui Biological Technology Co., Ltd. has issued convertible bonds with a total amount of RMB 328.2 million, and there are conditions under which these bonds may be redeemed if the stock price remains above a certain threshold [1][4]. Group 1: Convertible Bond Issuance - The company issued 3,281,967 convertible bonds at a face value of RMB 100 each, totaling RMB 328,196,700, with a term of 6 years [1]. - The convertible bonds were approved by the China Securities Regulatory Commission and began trading on September 6, 2023 [2]. Group 2: Conversion Terms - The conversion period for the bonds is from February 26, 2024, to August 17, 2029 [2]. - The initial conversion price was set at RMB 12.87 per share, which was later adjusted to RMB 8.89 per share on September 19, 2024, and subsequently to RMB 8.87 per share effective May 28, 2025 [3]. Group 3: Conditional Redemption Clause - The company has the right to redeem the bonds if the stock price reaches or exceeds 130% of the conversion price, which is RMB 11.531 per share [1][4]. - As of August 13, 2025, the stock price has met this condition for 10 trading days, indicating a potential for redemption [5].